Aetion Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
288
- Latest Deal Type
-
Later Stage VC
- Investors
-
20
Aetion General Information
Description
Operator of a healthcare analytics company intended to offer real-world analytics and evidence to transform real-world data into decisions. The company's platform uses everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments, enabling biopharma clients and payers to collaborate in real-time and develop therapeutic insights so that patients get the required care that is both clinically and cost-effective.
Contact Information
Website
www.aetion.comCorporate Office
- 5 Penn Plaza
- 7th Floor
- New York, NY 10001
- United States
Corporate Office
- 5 Penn Plaza
- 7th Floor
- New York, NY 10001
- United States
Aetion Timeline
Aetion Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC | 15-Apr-2024 | 00000 | Completed | Generating Revenue | ||
6. Later Stage VC (Series C) | 11-May-2021 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
5. Later Stage VC (Series B1) | 26-Aug-2020 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
4. Later Stage VC (Series B1) | 04-Feb-2019 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
3. Later Stage VC (Series B) | 14-Mar-2018 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
2. Later Stage VC (Series A) | 17-May-2017 | $11.2M | $11.2M | 000.00 | Completed | Generating Revenue |
1. Seed Round | 01-Sep-2016 | Completed | Startup |
Aetion Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 0,000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
Series B1 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series B | 7,589,810 | $0.000100 | 8% | $4.8 | $4.8 | 1x | $4.8 | 17.18% |
Series A | 3,238,797 | $0.000100 | 8% | $4.05 | $4.05 | 1x | $4.05 | 7.33% |
Aetion Comparisons
Industry
Financing
Details
Aetion Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Pieces (Decision/Risk Analysis) | Venture Capital-Backed | Irving, TX | 00 | 000.00 | 00000000000 | 000.00 |
HealthVerity | Venture Capital-Backed | Philadelphia, PA | 000 | 00000 | 00000000000 | 00000 |
TriNetX | Private Equity-Backed | Cambridge, MA | 000 | 00000 | 000000000000 | 00000 |
Doctor Evidence | Venture Capital-Backed | Santa Monica, CA | 00 | 00.00 | 00000000000 | 00.00 |
MedNet (Healthcare Technology Systems) | Venture Capital-Backed | Minnetonka, MN | 00 | 000.00 | 00000000000 | 000.00 |
Aetion Patents
Aetion Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11011255-B1 | Template driven reporting system for a longitudinal database | Active | 17-Aug-2015 | 0000000000 | 00 |
US-10762094-B1 | Patient variable language for a longitudinal database | Active | 17-Aug-2015 | 0000000000 | 00 |
US-10347370-B1 | Deriving a patient level longitudinal database for rapid cycle analytics | Active | 17-Aug-2015 | 000000000 | 00 |
US-20150142821-A1 | Database system for analysis of longitudinal data sets | Active | 18-Nov-2013 | 00 | |
US-9378271-B2 | Database system for analysis of longitudinal data sets | Active | 18-Nov-2013 | 00 |
Aetion Executive Team (33)
Name | Title | Board Seat |
---|---|---|
Carolyn Magill | Chief Executive Officer & Board Member | |
Jeremy Rassen | Co-Founder, President, Co-Chief Technology Officer and Board Director | |
Thomas Wright | Chief Financial Officer | |
David Vavrasek | Chief Business Officer & General Manager of Technology | |
Nicolle Gatto Ph.D | Chief Science Officer & Senior Vice President of Scientific Research |
Aetion Board Members (16)
Name | Representing | Role | Since |
---|---|---|---|
Adair Newhall | Self | Board Observer | 000 0000 |
Anshul Agarwal | LG Technology Ventures | Board Observer | 000 0000 |
Carolyn Magill | Aetion | Chief Executive Officer & Board Member | 000 0000 |
Cathy Polinsky | Self | Board Member | 000 0000 |
Cris De Luca | Sanofi Ventures | Board Observer | 000 0000 |
Aetion Signals
Aetion Investors (20)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Blue Lion Global | Venture Capital | Minority | 000 0000 | 000000 0 |
LG Technology Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
B Capital Group | Venture Capital | Minority | 000 0000 | 000000 0 |
Foresite Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 |
Warburg Pincus | PE/Buyout | Minority | 000 0000 | 000000 0 |
Aetion Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Replica Analytics | 04-Jan-2022 | 0000000000 | Database Software | 000000 00 |
Aetion FAQs
-
When was Aetion founded?
Aetion was founded in 2012.
-
Who is the founder of Aetion?
Michael Ruhl Ph.D, Jeremy Rassen, Allon Rauer, and Sebastian Schneeweiss MD are the founders of Aetion.
-
Who is the CEO of Aetion?
Carolyn Magill is the CEO of Aetion.
-
Where is Aetion headquartered?
Aetion is headquartered in New York, NY.
-
What is the size of Aetion?
Aetion has 288 total employees.
-
What industry is Aetion in?
Aetion’s primary industry is Decision/Risk Analysis.
-
Is Aetion a private or public company?
Aetion is a Private company.
-
What is Aetion’s current revenue?
The current revenue for Aetion is 00000.
-
How much funding has Aetion raised over time?
Aetion has raised $204M.
-
Who are Aetion’s investors?
Blue Lion Global, LG Technology Ventures, B Capital Group, Foresite Capital, and Warburg Pincus are 5 of 20 investors who have invested in Aetion.
-
Who are Aetion’s competitors?
Pieces (Decision/Risk Analysis), HealthVerity, TriNetX, Doctor Evidence, and MedNet (Healthcare Technology Systems) are some of the 8 competitors of Aetion.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »